Leukemia

Myeloid and Monocytic LeukemiaA Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients
Myeloid and Monocytic LeukemiaA Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7 + 3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who Are Considered High-Risk (Adverse) Acute Myeloid Leukemia As Determined by MYELOMATCH; A MYELOMATCH Clinical Trial
Leukemia, not otherwise specified, PediatricsA Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Myeloid and Monocytic LeukemiaPhase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell LymphomaPrincipal Investigator: Tarsheen Sethi
Myeloid and Monocytic LeukemiaA Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)